BGF World Healthscience D2 USD/ LU0329593007 /
| NAV7/1/2022 | Chg.+0.2600 | Type of yield | Investment Focus | Investment company |
|---|---|---|---|---|
| 67.8000USD | +0.39% | reinvestment | Equity Worldwide | BlackRock (LU) ▶ |
Monthly performance
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2016 | -10.33 | -0.33 | 1.52 | 4.23 | 2.31 | -0.55 | 5.34 | -3.21 | -0.65 | -6.31 | 1.40 | 0.06 | -7.35% |
| 2017 | 1.58 | 7.56 | 0.42 | 2.52 | 1.53 | 3.60 | 0.17 | -0.22 | 1.17 | -0.12 | 2.04 | 0.64 | +22.71% |
| 2018 | 6.42 | -4.18 | -3.54 | 2.45 | 2.07 | 1.48 | 4.13 | 4.16 | 2.73 | -6.10 | 4.57 | -7.34 | +5.81% |
| 2019 | 4.78 | 3.21 | 0.27 | -3.16 | -1.60 | 6.96 | 2.18 | -0.16 | -1.39 | 4.86 | 4.33 | 2.99 | +25.26% |
| 2020 | -0.12 | -8.39 | -2.74 | 11.66 | 3.75 | -1.39 | 5.91 | 1.33 | -1.36 | -4.86 | 8.08 | 3.80 | +14.86% |
| 2021 | 1.85 | -2.58 | 1.41 | 4.85 | 1.05 | 2.48 | 1.90 | 1.77 | -4.36 | 2.22 | -2.31 | 6.33 | +15.05% |
| 2022 | -8.19 | -0.50 | 6.10 | -3.31 | -1.50 | -2.16 | 0.39 | - | - | - | - | - | - |
Calculated values
| YTD | 6 Months | 1 Year | 3 Years | 5 Years | |
|---|---|---|---|---|---|
| Volatility | 19.19% | 19.26% | 15.63% | 16.97% | 15.55% |
| Sharpe ratio | -0.92 | -0.77 | -0.31 | 0.62 | 0.69 |
| Best month | +6.33% | +6.10% | +6.33% | +11.66% | +11.66% |
| Worst month | -8.19% | -8.19% | -8.19% | -8.39% | -8.39% |
| Maximum loss | -15.59% | -15.35% | -15.62% | -26.07% | -26.07% |
| Outperformance | +1.14% | - | -2.20% | +12.47% | +26.14% |
All quotes in USD
Tranches
| Name | Type of yield | Repurchase p. | 1 Year | 3 Years | |
|---|---|---|---|---|---|
| BGF World Healthscience A2 AUD H | reinvestment | 20.2400 | -6.77% | +25.79% | |
| BGF World Healthscience A2 HKD H | reinvestment | 208.1500 | -6.11% | +30.53% | |
| BGF World Healthscience A2 SGD H | reinvestment | 20.6600 | -6.01% | +28.80% | |
| BGF World Healthscience C2 EUR | reinvestment | 45.1300 | +6.26% | +37.68% | |
| BGF World Healthscience A2 CNH H | reinvestment | 178.8500 | -3.94% | +37.30% | |
| BGF World Healthscience D2 USD | reinvestment | 67.8000 | -5.06% | +34.26% | |
| BGF World Healthscience D2 EUR | reinvestment | 65.1900 | +8.43% | +46.20% | |
| BGF World Healthscience D4 EUR | paying dividend | 15.4600 | -5.04% | +34.26% | |
| BGF World Healthscience X2 USD | reinvestment | 75.8100 | -4.12% | +38.31% | |
| BGF World Healthscience E2 USD | reinvestment | 54.6500 | -6.24% | +29.32% | |
| BGF World Healthscience A4 EUR | paying dividend | 11.0100 | +7.52% | - | |
| BGF World Healthscience A4 USD | paying dividend | 11.4600 | -5.76% | - | |
| BGF World Healthscience A2 EUR H | reinvestment | 13.6900 | -7.12% | +24.68% | |
| BGF World Healthscience E2 EUR | reinvestment | 52.5400 | +7.07% | +40.82% | |
| BGF World Healthscience A2 USD | reinvestment | 60.6900 | -5.78% | +31.25% | |
| BGF World Healthscience A2 EUR | reinvestment | 58.3500 | +7.60% | +42.94% |
Performance
| YTD | -9.32% | ||
|---|---|---|---|
| 6 Months | -7.65% | ||
| 1 Year | -5.06% | ||
| 3 Years | +34.26% | ||
| 5 Years | +64.68% | ||
| Since start | +85.75% | ||
| Year | |||
| 2021 | +15.05% | ||
| 2020 | +14.86% | ||
| 2019 | +25.26% | ||
| 2018 | +5.81% | ||
| 2017 | +22.71% | ||
| 2016 | -7.35% | ||